[HTML][HTML] Exercise-based cardio-oncology rehabilitation for cardiotoxicity prevention during breast Cancer chemotherapy: The ONCORE randomized controlled trial
E Díaz-Balboa, C Pena-Gil… - Progress in …, 2024 - Elsevier
Background Breast cancer (BC) treatment with anthracyclines and/or anti-human epidermal
growth factor receptor-2 (HER2) antibodies is associated with an increased risk of …
growth factor receptor-2 (HER2) antibodies is associated with an increased risk of …
Exercise-based cardio-oncology rehabilitation for cardiotoxicity prevention during breast Cancer chemotherapy: The ONCORE randomized controlled trial.
E Díaz-Balboa, C Pena-Gil… - Progress in …, 2024 - europepmc.org
Background Breast cancer (BC) treatment with anthracyclines and/or anti-human epidermal
growth factor receptor-2 (HER2) antibodies is associated with an increased risk of …
growth factor receptor-2 (HER2) antibodies is associated with an increased risk of …
Exercise-based cardio-oncology rehabilitation for cardiotoxicity prevention during breast Cancer chemotherapy: The ONCORE randomized controlled trial
E Díaz-Balboa, C Pena-Gil… - Progress in … - pubmed.ncbi.nlm.nih.gov
Background Breast cancer (BC) treatment with anthracyclines and/or anti-human epidermal
growth factor receptor-2 (HER2) antibodies is associated with an increased risk of …
growth factor receptor-2 (HER2) antibodies is associated with an increased risk of …